Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 10, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-03
DOI
10.1186/s13195-018-0439-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
- (2017) Lauren M Byrne et al. LANCET NEUROLOGY
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration
- (2016) Henrik Zetterberg NEURON
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia
- (2016) Lieke H. Meeter et al. Annals of Clinical and Translational Neurology
- Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
- (2016) Petra Steinacker et al. Scientific Reports
- Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
- (2015) Patrick Weydt et al. ANNALS OF NEUROLOGY
- Evolving brain structural changes in PSEN1 mutation carriers
- (2015) Roser Sala-Llonch et al. NEUROBIOLOGY OF AGING
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease
- (2013) Maria C. Carrillo et al. Alzheimers & Dementia
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
- (2013) S.M. Mills et al. REVUE NEUROLOGIQUE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations
- (2011) Juan Fortea et al. Neurodegenerative Diseases
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
- (2011) Randall J Bateman et al. Alzheimers Research & Therapy
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now